These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7090999)

  • 1. Effect of isoproterenol on the anterograde refractory period of the accessory pathway in patients with the Wolff-Parkinson-White syndrome.
    Wellens HJ; Brugada P; Roy D; Weiss J; Bär FW
    Am J Cardiol; 1982 Jul; 50(1):180-4. PubMed ID: 7090999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of the ajmaline-procainamide test to predict the effect of long-term oral amiodarone on the anterograde effective refractory period of the accessory pathway in the Wolff-Parkinson-White syndrome.
    Brugada P; Dassen WR; Braat S; Gorgels AP; Wellens HJ
    Am J Cardiol; 1983 Jul; 52(1):70-2. PubMed ID: 6858931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oral amiodarone on rate-dependent changes in refractoriness in patients with Wolff-Parkinson-White syndrome.
    Brugada P; Wellens HJ
    Am J Cardiol; 1985 Nov; 56(13):863-6. PubMed ID: 4061328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of atropine and isoproterenol on tachycardia induction in asymptomatic patients with Wolff-Parkinson-White electrocardiographic pattern.
    Kim YH; Leitch JW; Klein GJ; Yee R; Leather RA
    Can J Cardiol; 1992 Sep; 8(7):716-20. PubMed ID: 1422992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of flestolol on ventricular rate during atrial fibrillation in Wolff-Parkinson-White syndrome.
    Swerdlow CD; Peterson J; Liem LB
    Am J Cardiol; 1988 Jul; 62(1):78-82. PubMed ID: 2898208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of isoproterenol on accessory pathway conduction in intermittent or concealed Wolff-Parkinson-White syndrome.
    Yamamoto T; Yeh SJ; Lin FC; Wu DL
    Am J Cardiol; 1990 Jun; 65(22):1438-42. PubMed ID: 2353648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation.
    Kappenberger LJ; Fromer MA; Steinbrunn W; Shenasa M
    Am J Cardiol; 1984 Aug; 54(3):330-5. PubMed ID: 6465013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transesophageal versus intracardiac atrial stimulation in assessing anterograde conduction properties of the accessory pathway in Wolff-Parkinson-White syndrome.
    Favale S; Minafra F; Massari V; Tritto M; Rizzon P
    Int J Cardiol; 1991 Feb; 30(2):209-14. PubMed ID: 2010244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoprenaline and inducibility of atrioventricular nodal re-entrant tachycardia.
    Hatzinikolaou H; Rodriguez LM; Smeets JL; Timmermans C; Vrouchos G; Grecas G; Wellens HJ
    Heart; 1998 Feb; 79(2):165-8. PubMed ID: 9538310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of exercise on the permeability of accessory pathways and supraventricular arrhythmia in Wolff-Parkinson-White syndrome].
    Mabo P; Kermarrec A; Gras D; Paillard F; Bédossa M; Daubert C
    Arch Mal Coeur Vaiss; 1992 Oct; 85(10):1443-8. PubMed ID: 1297293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of verapamil on the electrophysiologic properties of the accessory pathway in patients with the Wolff-Parkinson-White syndrome.
    Harper RW; Whitford E; Middlebrook K; Federman J; Anderson S; Pitt A
    Am J Cardiol; 1982 Dec; 50(6):1323-30. PubMed ID: 7148709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of abrupt cycle length changes on the refractoriness of accessory pathway, His-Purkinje system, atrial and ventricular myocardium in Wolff-Parkinson-White syndrome.
    Shenasa M; Lacombe P; Cardinal R; Pagé P; Sadr-Ameli MA
    Pacing Clin Electrophysiol; 1989 Jan; 12(1 Pt 1):29-40. PubMed ID: 2464809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome.
    Wellens HJ; Brugada P; Abdollah H
    Am Heart J; 1983 Oct; 106(4 Pt 2):876-80. PubMed ID: 6613833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of drugs in the Wolff-Parkinson-White syndrome. Importance of initial length of effective refractory period of the accessory pathway.
    Wellens HJ; Bär FW; Dassen WR; Brugada P; Vanagt EJ; Farré J
    Am J Cardiol; 1980 Oct; 46(4):665-9. PubMed ID: 7416026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation in Wolff-Parkinson-White syndrome: reversal of isoproterenol effects by sotalol.
    Madrid AH; Moro C; Maŕin Huerta EM; Novo L; Mestre JL
    Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2111-5. PubMed ID: 1279609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a combination of disopyramide and mexiletine on the anterograde accessory pathway conduction in patients with Wolff-Parkinson-White syndrome.
    Shimizu W; Ohe T; Kurita T; Takaki H; Aihara N; Kamakura S; Matsuhisa M; Shimomura K
    Eur Heart J; 1992 Feb; 13(2):261-8. PubMed ID: 1555626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias.
    Abdollah H; Brugada P; Green M; Wehr M; Wellens HJ
    Am J Cardiol; 1984 Sep; 54(6):544-9. PubMed ID: 6433688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of isoproterenol and amiodarone and the role of exercise in initiation of circus movement tachycardia in the accessory atrioventricular pathway.
    Brugada P; Facchini M; Wellens HJ
    Am J Cardiol; 1986 Jan; 57(1):146-9. PubMed ID: 3942059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of amiodarone in the Wolff-Parkinson-White syndrome.
    Wellens HJ; Lie KI; Bär FW; Wesdorp JC; Dohmen HJ; Düren DR; Durrer D
    Am J Cardiol; 1976 Aug; 38(2):189-94. PubMed ID: 952262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of the exercise test to predict the anterograde refractory period of the accessory pathway in Wolff Parkinson White syndrome.
    Daubert C; Ollitrault J; Descaves C; Mabo P; Ritter P; Gouffault J
    Pacing Clin Electrophysiol; 1988 Aug; 11(8):1130-8. PubMed ID: 2459665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.